424 filings
Page 10 of 22
6-K
76q3s
9 Mar 20
1. Details of the person discharging managerial responsibilities / person closely associated
2:07pm
6-K
y0yd7sc
9 Mar 20
1. Details of the person discharging managerial responsibilities / person closely associated
2:04pm
6-K
1f7ldiyq lnh48w
9 Mar 20
1. Details of the person discharging managerial responsibilities / person closely associated
2:02pm
6-K
74uagau9uszkyn4
9 Mar 20
1. Details of the person discharging managerial responsibilities / person closely associated
1:58pm
6-K
jb0e89yg7
9 Mar 20
1. Details of the person discharging managerial responsibilities / person closely associated
1:49pm
6-K
w5mcvnj8 3293lui
9 Mar 20
1. Details of the person discharging managerial responsibilities / person closely associated
1:47pm
6-K
uwzxbxgmswal82qbg6js
6 Mar 20
1. Details of the person discharging managerial responsibilities / person closely associated
6:15am
6-K
814l9qleyj
6 Mar 20
1. Details of the person discharging managerial responsibilities / person closely associated
6:15am
6-K
o27 pxh4zkvzes9wsq
6 Mar 20
1. Details of the person discharging managerial responsibilities / person closely associated
6:15am
6-K
e5li8
5 Mar 20
Current report (foreign)
8:03am
6-K
onxb41
4 Mar 20
Current report (foreign)
10:32am
6-K
77e6jejlrjljj5
2 Mar 20
Announcement of a subscription rights offering for the 0.5% qualified subordinated mandatory convertible bond 2020/2024
6:05am
FWP
cwmgegxonjaep1
27 Feb 20
Free writing prospectus
9:42pm
424B3
an8k6xxk lar7z
26 Feb 20
Prospectus supplement
5:05pm
6-K
hlao4q7juvxvrld
26 Feb 20
Current report (foreign)
8:48am
6-K
sjl7 r8vt
19 Feb 20
Biofrontera provides clinical development updates
7:56am
EFFECT
r0mpttoe
19 Feb 20
Notice of effectiveness
12:15am
424B3
nr2qbngi89b bprvw
18 Feb 20
Prospectus supplement
4:59pm
CORRESP
p5zqe71 bu
13 Feb 20
Correspondence with SEC
12:00am
CORRESP
hxkf rz165tsh71ry5
13 Feb 20
Correspondence with SEC
12:00am